Stay updated on CT-P16 vs Avastin in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the CT-P16 vs Avastin in Lung Cancer Clinical Trial page.
Latest updates to the CT-P16 vs Avastin in Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the intervention type to 'Verified 2022-08 by Celltrion' with a new active status, while also revising the version from v2.13.3 to v2.14.0.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference5%
- Check53 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference7%
- Check60 days agoChange DetectedSeveral key health-related links have been removed, including resources from MedlinePlus and NIH, which may impact access to information on genetics and lung cancer.SummaryDifference0.7%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, adding several new resources related to genetics and lung cancer, including links to MedlinePlus and NIH, while removing the previous version v2.12.1.SummaryDifference8%
Stay in the know with updates to CT-P16 vs Avastin in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P16 vs Avastin in Lung Cancer Clinical Trial page.